Jan Lapins

5.2k total citations · 2 hit papers
54 papers, 2.5k citations indexed

About

Jan Lapins is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Jan Lapins has authored 54 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Dermatology, 22 papers in Oncology and 15 papers in Epidemiology. Recurrent topics in Jan Lapins's work include Cutaneous Melanoma Detection and Management (21 papers), Hidradenitis Suppurativa and Treatments (14 papers) and Nonmelanoma Skin Cancer Studies (11 papers). Jan Lapins is often cited by papers focused on Cutaneous Melanoma Detection and Management (21 papers), Hidradenitis Suppurativa and Treatments (14 papers) and Nonmelanoma Skin Cancer Studies (11 papers). Jan Lapins collaborates with scholars based in Sweden, Denmark and Germany. Jan Lapins's co-authors include Lennart Emtestam, Gregor B. E. Jemec, Karin Sartorius, Christos C. Zouboulis, J. Revuz, Errol P. Prens, Łukasz Matusiak, István Juhász, Sylke Schneider‐Burrus and Jacek C. Szepietowski and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Scientific Reports.

In The Last Decade

Jan Lapins

51 papers receiving 2.4k citations

Hit Papers

European S1 guideline for the treatment of hidradenitis ... 2009 2026 2014 2020 2015 2009 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Lapins Sweden 20 2.1k 1.7k 731 191 165 54 2.5k
Magdalene Dohil United States 16 504 0.2× 307 0.2× 178 0.2× 82 0.4× 61 0.4× 27 1.1k
Claudio Conforti Italy 20 637 0.3× 88 0.1× 362 0.5× 395 2.1× 171 1.0× 115 1.2k
Monique R.T.M. Thissen Netherlands 20 863 0.4× 170 0.1× 1.1k 1.5× 427 2.2× 282 1.7× 32 1.5k
A Tromm Germany 20 186 0.1× 260 0.2× 569 0.8× 60 0.3× 111 0.7× 51 997
Kurt Gebauer Australia 21 937 0.4× 72 0.0× 722 1.0× 225 1.2× 184 1.1× 61 1.6k
Isabel Betlloch Spain 17 471 0.2× 187 0.1× 343 0.5× 97 0.5× 54 0.3× 127 992
A.B. Alexandroff United Kingdom 15 148 0.1× 547 0.3× 199 0.3× 238 1.2× 210 1.3× 41 1.3k
Mark Ling United States 21 1.1k 0.5× 53 0.0× 684 0.9× 245 1.3× 164 1.0× 34 1.7k
Sílvio Tatti Argentina 16 59 0.0× 392 0.2× 914 1.3× 268 1.4× 78 0.5× 46 1.1k
Harley A. Haynes United States 15 457 0.2× 66 0.0× 432 0.6× 177 0.9× 120 0.7× 32 1.0k

Countries citing papers authored by Jan Lapins

Since Specialization
Citations

This map shows the geographic impact of Jan Lapins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Lapins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Lapins more than expected).

Fields of papers citing papers by Jan Lapins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Lapins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Lapins. The network helps show where Jan Lapins may publish in the future.

Co-authorship network of co-authors of Jan Lapins

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Lapins. A scholar is included among the top collaborators of Jan Lapins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Lapins. Jan Lapins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Portelli, Francesca, et al.. (2025). Desmoplastic melanoma in Sweden in 2009–2022: A population‐based registry study demonstrating distinctive tumour characteristics, incidence and survival trends. Journal of the European Academy of Dermatology and Venereology. 40(1). 90–98. 2 indexed citations
2.
Helgadóttir, Hildur, K. Nielsen, Francesca Portelli, et al.. (2024). Melanoma Incidence and Mortality Trends Among Patients Aged 59 Years or Younger in Sweden. JAMA Dermatology. 160(11). 1201–1201. 6 indexed citations
3.
Kim, Jiyeong, Zhuo Ran Cai, Roxana Daneshjou, et al.. (2024). Human-AI interaction in skin cancer diagnosis: a systematic review and meta-analysis. npj Digital Medicine. 7(1). 78–78. 25 indexed citations
6.
Sun, Chengxi, Pilvi Riihilä, Liisa Nissinen, et al.. (2023). Long noncoding RNA plasmacytoma variant translocation 1 is overexpressed in cutaneous squamous cell carcinoma and exon 2 is critical for its oncogenicity. British Journal of Dermatology. 190(3). 415–426. 6 indexed citations
7.
Lapins, Jan, K. Nielsen, Ismini Vassilaki, et al.. (2023). Increasing melanoma incidence and survival trend shifts with improved melanoma-specific survival between 1990 and 2020 in Sweden. British Journal of Dermatology. 189(6). 702–709. 8 indexed citations
9.
Silander, Gustav, Åke Borg, Jenny Pettersson, et al.. (2021). CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015–2020: implications for novel national recommendations. Acta Oncologica. 60(7). 888–896. 9 indexed citations
10.
Helgadóttir, Hildur, Karolin Isaksson, Christian Ingvar, et al.. (2020). Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study. JNCI Journal of the National Cancer Institute. 113(3). 318–328. 19 indexed citations
11.
Helgadóttir, Hildur, Karolin Isaksson, Christian Ingvar, et al.. (2020). 1148P Multiple primary melanoma incidence trends over five decades, a nationwide population-based study. Annals of Oncology. 31. S766–S766.
12.
Pasquali, Lorenzo, Jonas Nørskov Søndergaard, Jan Lapins, et al.. (2019). 448 A comprehensive analysis of coding and non coding transcriptomic changes in cutaneous squamous cell carcinoma. Journal of Investigative Dermatology. 139(9). S292–S292. 9 indexed citations
13.
Lindelöf, B, Jan Lapins, & Henrik Dal. (2017). Shift in Occupational Risk for Basal Cell Carcinoma from Outdoor to Indoor Workers: A Large Population-based Case-control Register Study from Sweden. Acta Dermato Venereologica. 97(7). 830–833. 17 indexed citations
14.
Lyth, Johan, et al.. (2017). Reduced disease‐specific survival following a diagnosis of multiple primary cutaneous malignant melanomas—a nationwide, population‐based study. International Journal of Cancer. 141(11). 2243–2252. 14 indexed citations
15.
Lohcharoenkal, Warangkana, Masako Harada, Jakob Lovén, et al.. (2016). MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC. Journal of Investigative Dermatology. 136(12). 2485–2494. 32 indexed citations
16.
Saunte, Ditte Marie Lindhardt & Jan Lapins. (2015). Lasers and Intense Pulsed Light Hidradenitis Suppurativa. Dermatologic Clinics. 34(1). 111–119. 19 indexed citations
17.
Lyth, Johan, Hanna Eriksson, Johan Hansson, et al.. (2014). Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men. British Journal of Dermatology. 172(3). 700–706. 30 indexed citations
18.
Sartorius, Karin, Lennart Emtestam, Jan Lapins, & Ӧlle Johansson. (2010). Cutaneous PGP 9.5 distribution patterns in hidradenitis suppurativa. Archives of Dermatological Research. 302(6). 461–468. 7 indexed citations
19.
Sartorius, Karin, Lennart Emtestam, Gregor B. E. Jemec, & Jan Lapins. (2009). Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. British Journal of Dermatology. 161(4). 831–839. 403 indexed citations breakdown →
20.
Lapins, Jan, et al.. (1997). Skin and Mucosal Characteristics of Symptomatic Primary HIV-1 Infection. AIDS Patient Care and STDs. 11(2). 67–70. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026